来源: WSJ Markets ↗
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.
|
暂时无法翻译，请重试。
来源报道重点
Tempus AI could capture a lucrative slice of Moderna and Merck’s personalized cancer therapy business, with Personalis at the center of the bet.
在 WSJ Markets 阅读原始报道 ↗